| Bihar Legislative Assembly Speaker Uday Narayan Chaudhary and other delegates release a souvenir in Patna on Saturday. Picture by Ranjeet Kumar Dey |
Patna, Nov. 30: Bihar is set to benefit from a corpus of Rs 1,200 crore granted by the Centre to strengthen the drug regulatory mechanism in the states.
The central government has approved Rs 3,000 crore for strengthening the drug regulatory mechanism in the country, said the drug controller general of India, G.N. Singh, today.
He was speaking at the 15th convention of the All India Drug Control Officers’ Confederation organised in the city. Barring Rs 1,200 crore, the remaining funds would go into improving the central regulatory mechanism.
Singh also asked the Bihar drug control administration to constitute a vigilance cell for investigation of fake and sub-standard drugs.
He told The Telegraph that the Drug Control Authority of India was keeping tabs on fake and sub-standard drugs in Bihar by ensuring transparent check of samples.
He said: “In July, we collected drug samples from Bihar in a clandestine manner and checked them at a laboratory in another state.”
Representatives of pharmaceutical companies stressed on government assistance for firms eyeing investments.
B.N. Singh, the managing director of Alkem Laboratories, said: “Bihar, along with Jharkhand, Odisha, Madhya Pradesh and Uttar Pradesh, contribute 40 per cent of the Indian pharma market. So, it is the perfect destination for setting up a pharmaceutical wing. Land and labour is economical here. Companies can save on logistics if their factories are located in the state, but they won’t do so if the government does not help them with land acquisition and power.”